Clinical Trial Update: Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated the safety and efficacy of sodium polystyrene sulfonate in hyperkalemia. The study was terminated and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Sodium polystyrene sulfonate (Sodium polystyrene sulfonate)

Snippet

Sponsor: ZS Pharma, Inc. | Conditions: Hyperkalemia | Phase 4 | Status: TERMINATED | Results posted: 2014-09-03